Safety of Surveillance in the Management of Stage I Anaplastic Germ Cell Tumours of the Testis
- 1 March 1988
- journal article
- research article
- Published by Wiley in British Journal of Urology
- Vol. 61 (3) , 250-253
- https://doi.org/10.1111/j.1464-410x.1988.tb06389.x
Abstract
Summary— A study was made of 46 patients with anaplastic germ cell tumours of the testis with no evidence of disease elsewhere as judged by computed tomography (CT) of thorax and abdomen, ultrasound and tumour marker measurements. A repeat CT 3 months after the first and clinical examination with chest X-ray and tumour marker measurements ensured that the 30.7% of patients who relapsed were detected promptly enough for them all to enter complete remission. Lymphography as part of the staging did not reduce the relapse rate. There was no difference between this group and a comparable group who underwent radiotherapy to para-aortic lymph nodes.This publication has 11 references indexed in Scilit:
- Prognostic factors in stage I non-seminomatous germ-cell testicular tumors managed by orchiectomy and surveillance: implications for adjuvant chemotherapy.Journal of Clinical Oncology, 1986
- Toward more rational management for stage I testis cancer: watch out for "watch and wait"!Journal of Clinical Oncology, 1986
- Current Optimum Management of Anaplastic Germ Cell Tumours of the Testis and Other SitesBritish Journal of Urology, 1986
- Tumour markers in germ cell tumours.BMJ, 1986
- Prospective study of follow up alone in stage I teratoma of the testis.BMJ, 1983
- Computerized Tomography and Lymphangiography in Staging Testis TumorsJournal of Urology, 1981
- The role of computed tomography in the management of testicular teratomaClinical Radiology, 1979
- COMBINED MANAGEMENT OF MALIGNANT TERATOMA OF THE TESTISPublished by Elsevier ,1979